News in Brief
Qmetrics promos work on cartilage software CE Mark
May 11, 2012 -- Image analysis firm Qmetrics Technologies said its quantitative MRI cartilage evaluation technique helped Piramal Healthcare get a CE Mark for its BST-CarGel product for bioorthopedic cartilage repair.
iCAD reports first European Xoft treatments
May 11, 2012 -- Computer-aided detection vendor iCAD has announced that the first European patients have been treated with its Xoft Axxent electronic brachytherapy system.
Accenture lands NHS PACS extension
May 10, 2012 -- The U.K. Department of Health has given Accenture a one-year extension to continue to provide its PACS offering to National Health Service (NHS) Trusts in the northeast and east of England/East Midlands that have elected to extend their current service provision with the company.
CIVCO highlights new products at ESTRO 2012
May 10, 2012 -- Ultrasound and radiotherapy products developer CIVCO Medical Solutions is showcasing new products at this year's European Society for Radiotherapy and Oncology (ESTRO) meeting in Barcelona, Spain.
Accuray introduces TomoTherapy upgrade at ESTRO
May 9, 2012 -- Radiation oncology firm Accuray said it is introducing a new treatment planning system at this year's European Society for Radiotherapy and Oncology (ESTRO) meeting in Barcelona, Spain.
Dilon promotes declipseSPECT study results
May 9, 2012 -- Breast-specific gamma imaging developer Dilon Diagnostics is highlighting clinical research regarding its declipseSPECT device presented in March at the Society of Surgical Oncology annual cancer symposium.
Mirada Medical wins Oxford RTx contract
May 9, 2012 -- Imaging software developer Mirada Medical has won a contract for its RTx software with the Gray Institute for Radiation Oncology and Biology in Oxford, U.K., the company said.
Oncologic imaging group prepares for Croatia
May 9, 2012 -- The European Society of Oncologic Imaging (ESOI) plans to hold an Oncologic Imaging Course between 28 and 30 June in Dubrovnik, Croatia. The focus of the course will be thoracic, abdominal, and pelvic tumors, lymphoma and bone imaging, interventional oncology, and breast imaging.